Newsletter

141080 - LigaChem Biosciences Inc.

141080 Summary

Biopharma

Stock Price & Overview

₩89,300 -3,000 (-3.25%) Close · Sep 8, 2026 KST

KOSDAQ | ₩KRW | Close: ₩89,300 ≈ US$64 · Market cap ₩3.3tn (≈ $2.4bn)

Home › 141080 › Filings

Investor Relations Event

DART

LigaChem Biosciences Inc.

Filed Sep 8, 2026 KST · IR · receipt 20260908900085

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.

Korean form name: 기업설명회(IR)개최

141080

Price: ₩89,300
Change: -3.25%
Market cap: ₩3.3tn
Prev. close: ₩92,300

141080 Summary Compare to Peers

141080 data on kstock

Financials: 11 fiscal years
Valuation: Daily P/E, P/S, P/B, P/CF
Earnings: Eight quarters
Dividends: Per-share history

Every figure is taken from LigaChem Biosciences Inc.'s own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

kstock analysis on 141080

LigaChem Biosciences: It Is Now Paying To Keep A Drug It Co-Owned

Sep 2, 1:28 AM

All 141080 analysis

More 141080 filings

141080 - LigaChem Biosciences Inc.

Investor Relations Event

141080

141080 data on kstock

kstock analysis on 141080

LigaChem Biosciences: It Is Now Paying To Keep A Drug It Co-Owned

More 141080 filings

Large business group status disclosure — quarterly, individual company

Half-Year Report

Supplier Payment Terms and Dispute-Resolution Disclosure

Material matter affecting investment judgment

5% Ownership Report — Large Holdings ×2

Insider / Major Shareholder Holdings Report